Greencare Capital is targeting opportunities amid what it described as a “rapidly changing regulatory environment” for medical cannabis, hemp and CBD wellness.
The company said it wants to invest in opportunities within countries that have well-developed and reputable laws and regulations.
It intends to invest directly or indirectly in ‘public or private companies, in supply and distribution chains, or other business associated with the sector’. Either debt or equity based investment opportunities will be considered, it added.
“We are extremely excited by the significant investment opportunity. We aim to take advantage of value disparities within the relatively immature sector and are already considering a number of potential investments,” said Fabio Carretta, Greencare Capital chief executive.
“Being on NEX will enable us to implement our investment strategy by improving our negotiating position and providing access to further funding should it be required.”
Greencare raised £515,000 in its NEX float, with 2.05mln new shares (which represent about 17% of the company) and, with a debut price of 25p per share the company’s market capitalisation is set at around £3mln.
The company aims to complete due diligence on its first investment shortly and said it will update the market in due course.